← Azimuth Daily
Capturing data…
Capturing data…
MON, 19 OCT · 85 ITEMS
"Implant restores vision in macular degeneration patients, study shows" — MIT Technology Review · Science & Medicine
The wireless has been shown in a recent study to restore central vision in patients with advanced age-related (specifically ). The implant is placed under the retina and wirelessly receives light signals, allowing patients to perceive letters, faces, and objects—essentially reversing some vision loss from a disease that affects over five million people worldwide.
The claim is based on clinical trial results published in a peer-reviewed journal (likely the New England Journal of Medicine, as earlier reports suggest) and reported by MIT Technology Review, a reputable secondary source that directly covers the original study. The reporting is close to the primary source and includes specific patient outcomes, making the claim well-supported.
This is genuinely new coverage from October 16, 2026, providing an update on the PRIMA implant—the underlying clinical trial results were first published in late 2025, but this article presents fresh details or a milestone such as European regulatory availability.
We covered the initial clinical trial results of the PRIMA implant in October 2025, when Stanford Medicine, UPMC, and Nature reported that patients with advanced regained enough central vision to read letters and recognize faces. This new article updates those results with additional context, such as the implant's expanded availability.